Chardan Capital Reiterates Buy on Applied Molecular, Maintains $3 Price Target
Chardan Capital analyst Matthew Barcus reiterates Applied Molecular (NASDAQ:AMTI) with a Buy and maintains $3 price target.
B of A Securities Downgrades Applied Molecular to Underperform, Lowers Price Target to $0.5
B of A Securities analyst Jason Gerberry downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Underperform and lowers the price target from $5 to $0.5.
Applied Molecular Transport To $2? Here Are Other Price Target Changes For Tuesday
SVB Leerink cut Applied Molecular Transport Inc. (NASDAQ:AMTI) price target from $15 to $2. SVB Leerink analyst Joseph…
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 325 companies set new 52-week lows.
SVB Leerink Downgrades Applied Molecular to Market Perform, Lowers Price Target to $2
SVB Leerink analyst Joseph Schwartz downgrades Applied Molecular (NASDAQ:AMTI) from Outperform to Market Perform and lowers the price target from $15 to $2.
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Scopus BioPharma (NASDAQ:SCPS) stock rose 50.0% to $0.12 during Monday’s regular session. The current volume of 120.0K…
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Immuron (NASDAQ:IMRN) stock rose 42.9% to $2.3 during Monday’s pre-market session. The market value of their outstanding…
Dow Rises 150 Points; Mission Produce Shares Slide
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday.
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Immuron (NASDAQ:IMRN) shares increased by 37.9% to $2.22 during Friday’s regular session. As of 12:30 EST, this…